Overview
MDXG market data
Price History
MDXG price chart
Valuation & Profitability
- P/E (TTM)
- 99.76 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $0.32 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.22 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 1.8% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $3.03 – $7.97 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $622.4M · P/B 3.91 · P/S 1.75.
Company News
8-K/A filing — MIMEDX GROUP, INC. (MDXG)SEC EDGAR · Aug 11, 2026, 8:44 PM
Meta Posts Mixed Q2 Results, Joins Coursera, Qualcomm And Other Big Stocks Moving Lower In Thursday’s Pre-Market SessionBenzinga · Jul 30, 2026, 12:02 PM
MiMedx Group shares are trading lower. The company reported Q2 financial results.Benzinga · Jul 29, 2026, 8:40 PM
MiMedx Group Affirms FY2026 Sales Guidance of $260.000M-$290.000M vs $269.440M EstBenzinga · Jul 29, 2026, 8:12 PM
MiMedx Group Q2 Adj. EPS $(0.05), Inline, Sales $64.362M Beat $63.460M EstimateBenzinga · Jul 29, 2026, 8:12 PM
8-K filing — MIMEDX GROUP, INC. (MDXG)SEC EDGAR · Jul 29, 2026, 8:08 PM
MIMEDX Acquires Sanara MedTech For ~$350MBenzinga · Jul 29, 2026, 8:01 PM